117 related articles for article (PubMed ID: 16524453)
1. Recent translational research: stem cells as the roots of breast cancer.
Chang CC
Breast Cancer Res; 2006; 8(1):103. PubMed ID: 16524453
[TBL] [Abstract][Full Text] [Related]
2. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
[TBL] [Abstract][Full Text] [Related]
3. Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?
Fillmore C; Kuperwasser C
Breast Cancer Res; 2007; 9(3):303. PubMed ID: 17540049
[TBL] [Abstract][Full Text] [Related]
4. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.
Abraham BK; Fritz P; McClellan M; Hauptvogel P; Athelogou M; Brauch H
Clin Cancer Res; 2005 Feb; 11(3):1154-9. PubMed ID: 15709183
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.
Theodoropoulos PA; Polioudaki H; Agelaki S; Kallergi G; Saridaki Z; Mavroudis D; Georgoulias V
Cancer Lett; 2010 Feb; 288(1):99-106. PubMed ID: 19619935
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific promoters active in CD44+CD24-/low breast cancer cells.
Bauerschmitz GJ; Ranki T; Kangasniemi L; Ribacka C; Eriksson M; Porten M; Herrmann I; Ristimäki A; Virkkunen P; Tarkkanen M; Hakkarainen T; Kanerva A; Rein D; Pesonen S; Hemminki A
Cancer Res; 2008 Jul; 68(14):5533-9. PubMed ID: 18632604
[TBL] [Abstract][Full Text] [Related]
8. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas.
Mylona E; Giannopoulou I; Fasomytakis E; Nomikos A; Magkou C; Bakarakos P; Nakopoulou L
Hum Pathol; 2008 Jul; 39(7):1096-102. PubMed ID: 18495204
[TBL] [Abstract][Full Text] [Related]
10. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
[TBL] [Abstract][Full Text] [Related]
11. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
[TBL] [Abstract][Full Text] [Related]
12. Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene.
Deng T; Liu JC; Pritchard KI; Eisen A; Zacksenhaus E
Clin Cancer Res; 2009 Jan; 15(1):119-30. PubMed ID: 19118039
[TBL] [Abstract][Full Text] [Related]
13. Gene expression analysis in SV40-immortalized human breast luminal epithelial cells with stem cell characteristics using a cDNA microarray.
Park JS; Noh DY; Kim SH; Kim SH; Kong G; Chang CC; Lee YS; Trosko JE; Kang KS
Int J Oncol; 2004 Jun; 24(6):1545-58. PubMed ID: 15138599
[TBL] [Abstract][Full Text] [Related]
14. ALDH(+)/CD44(+)/CD24(-) expression in cells from body cavity fluids.
Krishan A; Sharma D; Sharma S; Hamelik RM; Ganjei-Azar P; Nadji M
Cytometry B Clin Cytom; 2010 May; 78(3):176-82. PubMed ID: 20043317
[TBL] [Abstract][Full Text] [Related]
15. Breast tumor-initiating cells isolated from patient core biopsies for study of hormone action.
Marsden CG; Wright MJ; Pochampally R; Rowan BG
Methods Mol Biol; 2009; 590():363-75. PubMed ID: 19763516
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer stem cells: an overview.
Ponti D; Zaffaroni N; Capelli C; Daidone MG
Eur J Cancer; 2006 Jun; 42(9):1219-24. PubMed ID: 16624548
[TBL] [Abstract][Full Text] [Related]
17. Adhesion proteins in the biology of breast cancer: contribution of CD44.
Herrera-Gayol A; Jothy S
Exp Mol Pathol; 1999 Jun; 66(2):149-56. PubMed ID: 10409443
[TBL] [Abstract][Full Text] [Related]
18. High susceptibility of a human breast epithelial cell type with stem cell characteristics to telomerase activation and immortalization.
Sun W; Kang KS; Morita I; Trosko JE; Chang CC
Cancer Res; 1999 Dec; 59(24):6118-23. PubMed ID: 10626801
[TBL] [Abstract][Full Text] [Related]
19. Investigating the link between epithelial-mesenchymal transition and the cancer stem cell phenotype: A mathematical approach.
Turner C; Kohandel M
J Theor Biol; 2010 Aug; 265(3):329-35. PubMed ID: 20648969
[TBL] [Abstract][Full Text] [Related]
20. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).
Wang HS; Hung Y; Su CH; Peng ST; Guo YJ; Lai MC; Liu CY; Hsu JW
Exp Cell Res; 2005 Mar; 304(1):116-26. PubMed ID: 15707579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]